ArticleCancer research and treatment2014

A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HM30181A, in Patients with Advanced Solid Cancer.

Hyun Jung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.